Literature DB >> 9296258

Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.

S N Finkelstein, S L Huber, P E Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9296258     DOI： 10.1177/106002809703100927

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  1 in total

Review 1.  Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia.

Authors:  P Y Cremieux; S N Finkelstein; E R Berndt; J Crawford; M B Slavin
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.